Neurology News

The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a press release.

Mothers with multiple sclerosis had an elevated incidence and prevalence of peripartum mental illness vs. mothers without MS and those with or without other chronic conditions, according to study results.

Pharmacy benefit managers overcharged for specialty generic medications — in many cases by hundreds and thousands of percent — for billions in profits, according to a report from the Federal Trade Commission, or FTC.

Tracking lipid variability may be a reliable method of predicting dementia and cognitive decline among community-dwelling older adults, according to new research from Neurology.

The COVID-19 pandemic forced investigators conducting clinical trials to use decentralized elements, such as telehealth, to continue their research.

Senators grilled Robert F. Kennedy Jr. about his views on vaccines, abortion and other health-related matters in a frequently contentious hearing Wednesday to assess his nomination to be the next U.S. health secretary.

An analysis of adults with malignant glioma revealed that men were diagnosed at a younger age and women had worse preoperative status, but researchers found no other sex-related differences or clinical advantage.

The FDA has granted 510(k) clearance to a Bay Area commercial stage medical technology company for its novel large-bore catheter stroke thrombectomy system.

Use of PubMed’s conflict-of-interest field has increased over time, but utilization remains limited, according to research published in PLOS One.